160 related articles for article (PubMed ID: 28445180)
1. Activation of the CXCR4 chemokine receptor enhances biological functions associated with B16 melanoma liver metastasis.
Mendt M; Cardier JE
Melanoma Res; 2017 Aug; 27(4):300-308. PubMed ID: 28445180
[TBL] [Abstract][Full Text] [Related]
2. Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells.
Murakami T; Maki W; Cardones AR; Fang H; Tun Kyi A; Nestle FO; Hwang ST
Cancer Res; 2002 Dec; 62(24):7328-34. PubMed ID: 12499276
[TBL] [Abstract][Full Text] [Related]
3. CXCR4 enhances adhesion of B16 tumor cells to endothelial cells in vitro and in vivo via beta(1) integrin.
Cardones AR; Murakami T; Hwang ST
Cancer Res; 2003 Oct; 63(20):6751-7. PubMed ID: 14583470
[TBL] [Abstract][Full Text] [Related]
4. Murine B16 melanomas expressing high levels of the chemokine stromal-derived factor-1/CXCL12 induce tumor-specific T cell chemorepulsion and escape from immune control.
Vianello F; Papeta N; Chen T; Kraft P; White N; Hart WK; Kircher MF; Swart E; Rhee S; Palù G; Irimia D; Toner M; Weissleder R; Poznansky MC
J Immunol; 2006 Mar; 176(5):2902-14. PubMed ID: 16493048
[TBL] [Abstract][Full Text] [Related]
5. CXCL12 loaded-dermal filler captures CXCR4 expressing melanoma circulating tumor cells.
Ieranò C; D'Alterio C; Giarra S; Napolitano M; Rea G; Portella L; Santagata A; Trotta AM; Barbieri A; Campani V; Luciano A; Arra C; Anniciello AM; Botti G; Mayol L; De Rosa G; Pacelli R; Scala S
Cell Death Dis; 2019 Jul; 10(8):562. PubMed ID: 31332163
[TBL] [Abstract][Full Text] [Related]
6. Activation of the A2B adenosine receptor in B16 melanomas induces CXCL12 expression in FAP-positive tumor stromal cells, enhancing tumor progression.
Sorrentino C; Miele L; Porta A; Pinto A; Morello S
Oncotarget; 2016 Sep; 7(39):64274-64288. PubMed ID: 27590504
[TBL] [Abstract][Full Text] [Related]
7. Stromal-derived factor-1 and its receptor, CXCR4, are constitutively expressed by mouse liver sinusoidal endothelial cells: implications for the regulation of hematopoietic cell migration to the liver during extramedullary hematopoiesis.
Mendt M; Cardier JE
Stem Cells Dev; 2012 Aug; 21(12):2142-51. PubMed ID: 22121892
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of chemokine receptor CXCR4 gene by RNA interference: Effects on the B16-F10 melanoma growth.
André ND; Silva VA; Watanabe MA; De Lucca FL
Oncol Rep; 2016 Apr; 35(4):2419-24. PubMed ID: 26883290
[TBL] [Abstract][Full Text] [Related]
9. [Effect of chemokine CXCL12 and its receptor CXCR4 on proliferation, migration and invasion of epithelial ovarian cancer cells].
Jiang YP; Wu XH; Xing HY; DU XY
Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):403-7. PubMed ID: 17697603
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of CXCR4 by SDF-KDEL in SBC-5 cells inhibits their migration in vitro and organ metastasis in vivo.
Ma N; Pang H; Shen W; Zhang F; Cui Z; Wang J; Wang J; Liu L; Zhang H
Int J Mol Med; 2015 Feb; 35(2):425-32. PubMed ID: 25504108
[TBL] [Abstract][Full Text] [Related]
11. Chemokine receptor CCR7 expression predicts poor outcome in uveal melanoma and relates to liver metastasis whereas expression of CXCR4 is not of clinical relevance.
van den Bosch T; Koopmans AE; Vaarwater J; van den Berg M; de Klein A; Verdijk RM
Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7354-61. PubMed ID: 24052640
[TBL] [Abstract][Full Text] [Related]
12. In vitro effects and mathematical modelling of CTCE-9908 (a chemokine receptor 4 antagonist) on melanoma cell survival.
Basson C; Phiri AE; Gandhi M; Anguelov R; Serem JC; Bipath P; Hlophe YN
Clin Exp Pharmacol Physiol; 2024 Jun; 51(6):e13865. PubMed ID: 38692577
[TBL] [Abstract][Full Text] [Related]
13. Preclinical development of a novel class of CXCR4 antagonist impairing solid tumors growth and metastases.
Portella L; Vitale R; De Luca S; D'Alterio C; Ieranò C; Napolitano M; Riccio A; Polimeno MN; Monfregola L; Barbieri A; Luciano A; Ciarmiello A; Arra C; Castello G; Amodeo P; Scala S
PLoS One; 2013; 8(9):e74548. PubMed ID: 24058588
[TBL] [Abstract][Full Text] [Related]
14. CXCR4 regulates the early extravasation of metastatic tumor cells in vivo.
Gassmann P; Haier J; Schlüter K; Domikowsky B; Wendel C; Wiesner U; Kubitza R; Engers R; Schneider SW; Homey B; Müller A
Neoplasia; 2009 Jul; 11(7):651-61. PubMed ID: 19568410
[TBL] [Abstract][Full Text] [Related]
15. Sensitization of B16 tumor cells with a CXCR4 antagonist increases the efficacy of immunotherapy for established lung metastases.
Lee CH; Kakinuma T; Wang J; Zhang H; Palmer DC; Restifo NP; Hwang ST
Mol Cancer Ther; 2006 Oct; 5(10):2592-9. PubMed ID: 17041104
[TBL] [Abstract][Full Text] [Related]
16. A locked, dimeric CXCL12 variant effectively inhibits pulmonary metastasis of CXCR4-expressing melanoma cells due to enhanced serum stability.
Takekoshi T; Ziarek JJ; Volkman BF; Hwang ST
Mol Cancer Ther; 2012 Nov; 11(11):2516-25. PubMed ID: 22869557
[TBL] [Abstract][Full Text] [Related]
17. Post-Sepsis State Induces Tumor-Associated Macrophage Accumulation through CXCR4/CXCL12 and Favors Tumor Progression in Mice.
Mota JM; Leite CA; Souza LE; Melo PH; Nascimento DC; de-Deus-Wagatsuma VM; Temporal J; Figueiredo F; Noushmehr H; Alves-Filho JC; Cunha FQ; Rego EM
Cancer Immunol Res; 2016 Apr; 4(4):312-22. PubMed ID: 26817997
[TBL] [Abstract][Full Text] [Related]
18. Modulating the interaction of CXCR4 and CXCL12 by low-molecular-weight heparin inhibits hepatic metastasis of colon cancer.
Ma L; Qiao H; He C; Yang Q; Cheung CH; Kanwar JR; Sun X
Invest New Drugs; 2012 Apr; 30(2):508-17. PubMed ID: 21080209
[TBL] [Abstract][Full Text] [Related]
19. CXCR4 signaling regulates metastasis of chemoresistant melanoma cells by a lymphatic metastatic niche.
Kim M; Koh YJ; Kim KE; Koh BI; Nam DH; Alitalo K; Kim I; Koh GY
Cancer Res; 2010 Dec; 70(24):10411-21. PubMed ID: 21056990
[TBL] [Abstract][Full Text] [Related]
20. The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.
Arya M; Patel HR; McGurk C; Tatoud R; Klocker H; Masters J; Williamson M
J Exp Ther Oncol; 2004 Dec; 4(4):291-303. PubMed ID: 15844659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
